ALB vs PAHC · rev $1.74B vs P/E 13, rev $1.52B
Albemarle Corp (ALB) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
ALB currently screens at market cap $8.00B. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the ALB and PAHC stock pages for the full models.
Not investment advice.